Invention Grant
- Patent Title: Substituted pyridines, pyridazines, pyrimidines, and 1,2,3-triazines as bruton's tyrosine kinase inhibitors
-
Application No.: US17823889Application Date: 2022-08-31
-
Publication No.: US12070457B2Publication Date: 2024-08-27
- Inventor: Guangxiu Dai , Kun Xiao
- Applicant: HUTCHISON MEDIPHARMA LIMITED
- Applicant Address: CN Shanghai
- Assignee: HUTCHISON MEDIPHARMA LIMITED
- Current Assignee: HUTCHISON MEDIPHARMA LIMITED
- Current Assignee Address: CN Shanghai
- Agency: Hoxie & Associates LLC
- Priority: CN 2010104062.2 2020.02.20 CN 2110169142.0 2021.02.07
- Main IPC: A61K31/4985
- IPC: A61K31/4985 ; A61K31/501 ; A61K31/506 ; A61K31/53 ; A61K31/5377 ; A61K45/06 ; A61P35/00 ; C07D487/04 ; C07D487/14 ; C07D519/00
Abstract:
The present invention relates to heteroaryl heterocyclic compounds, e.g., the compound of the formula shown below, pharmaceutical compositions comprising same, methods for preparing same, and uses thereof.
Public/Granted literature
- US20230043030A1 HETEROARYL HETEROCYCLIC COMPOUNDS AND USES THEREOF Public/Granted day:2023-02-09
Information query
IPC分类:
